日报更新时间：06-24 15:34
周报更新时间：06-25 22:35
今开价：18.19
最高价：18.46
成交量：398273.0
昨收价：18.41
最低价：18.05
最新价：18.44
中文名称：万基遗传
英文名称：Myriad Genetics
行业：医疗
简介：Myriad Genetics, Inc.是一家领先的分子诊断公司，致力于通过该评估发展中国家疾病的人员的风险转化试验的发现及商业化，为患者的生活带来改变，指导治疗决策和评估疾病进展和复发的危险
电话：1-801-5843600
Myriad Genetics公司是一家分子诊断公司，专注于在美国和国际上进行基因测序、个性化医学测试、预后医学测试的开发和营销，和Invitae Corporation(NVTA)是一个领域，不过研究的东西不同。万基遗传的业务主要分三个部分：基因研究、分子诊断和制药及临床服务。公司的分子诊断测试通过分析基因从而进行分析诊断，预判测试者晚年可能患病的风险及概率，并根据评估个测试者开具针对性的基因治疗方法。美国知名影星安吉丽娜·朱莉做乳房切除手术，就是根据Myriad Genetics公司的基因测序结果显示，其患乳腺癌的几率非常高而做的决定。万基遗传提供多种分子诊断测试，包括BRAC和BART分析，对遗传性乳腺癌、卵巢癌、大肠癌、子宫癌和遗传性黑色素瘤等进行预测。另外Myriad Genetics公司的myPath技术可以预测和诊断黑色素瘤、肺癌；myRisk可以预测遗传性癌症；PANEXIA预测胰腺癌；PREZEON提供癌症个性化检测；Prolaris预测前列腺癌；Vectra DA预测和诊断类风湿性关节炎。除了分子检测（基因测序），万基遗传公司还涉及生物制药、生物技术、医学研究、复用免疫试剂盒、全血培养和药物毒性前人体试验等诸多领域。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2017-06-21 | Marsh (Richard M) | General Counsel | Gift | 5555 | -- |
| 2017-02-22 | Henderson (John T) | Director | Buy | 400 | 18.57 |
| 2017-02-22 | Henderson (John T) | Director | Buy | 3600 | 18.58 |
| 2017-02-21 | Henderson (John T) | Director | Buy | 2000 | 18.81 |
| 2017-01-02 | Tobin (Bernard F) | Officer | Sell | 2631 | 16.93 |
| 2016-11-30 | Phanstiel (S Louise) | Director | Buy | 15024 | -- |
| 2016-11-30 | Henderson (John T) | Director | Buy | 15024 | -- |
| 2016-11-30 | Langer (Dennis H) | Director | Buy | 15024 | -- |
| 2016-11-30 | Best (Lawrence C) | Director | Buy | 15024 | -- |
| 2016-11-30 | Dreismann (Heinrich Ph.D.) | Director | Buy | 15024 | -- |
| 2016-11-30 | Gilbert (Walter) | Director | Buy | 15024 | -- |
| 2016-10-16 | Riggsbee (Richard Bryan) | Chief Financial Officer | Sell | 3522 | 19.31 |
| 2016-09-29 | Tobin (Bernard F) | Officer | Sell | 4661 | 20.58 |
| 2016-09-29 | Capone (Mark Christopher) | Chief Executive Officer | Sell | 9238 | 20.58 |
| 2016-09-29 | Riggsbee (Richard Bryan) | Chief Financial Officer | Sell | 5599 | 20.58 |
| 2016-09-29 | Mcdade Ralph L | Officer | Sell | 1641 | 20.58 |
| 2016-09-29 | Ford (Alexander) | Officer | Sell | 1937 | 20.58 |
| 2016-09-29 | Lanchbury (Jerry S) | Officer | Sell | 5459 | 20.58 |
| 2016-09-29 | King Gary A | Officer | Sell | 4050 | 20.58 |
| 2016-09-29 | Wenstrup (Richard) | Officer | Sell | 931 | 20.58 |
| 2016-09-29 | Marsh (Richard M) | General Counsel | Sell | 3646 | 20.58 |
| 2016-09-16 | King Gary A | Officer | Sell | 3721 | 20.92 |
| 2016-09-16 | Mcdade Ralph L | Officer | Sell | 2188 | 20.92 |
| 2016-09-16 | Lanchbury (Jerry S) | Officer | Sell | 4752 | 20.92 |
| 2016-09-16 | Capone (Mark Christopher) | Chief Executive Officer | Sell | 8042 | 20.92 |
| 2016-09-16 | Ford (Alexander) | Officer | Sell | 1335 | 20.92 |
| 2016-09-16 | Wenstrup (Richard) | Officer | Sell | 931 | 20.92 |
| 2016-09-16 | Marsh (Richard M) | General Counsel | Sell | 4606 | 20.92 |
| 2016-09-13 | Tobin (Bernard F) | Officer | Buy | 49608 | -- |
| 2016-09-13 | Marsh (Richard M) | General Counsel | Buy | 45077 | -- |
| 第 页, 共 4 页 首页 上页 下页 末页 | |||||
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Rice Hall James & Associates, LLC | 904913 | 1.23% | 104360 | 13.04% | 2019-03-31 |
| Consonance Capital Management LP | 3309206 | 4.51% | 938910 | 39.61% | 2019-03-31 |
| Frontier Capital Management CO Inc | 3363970 | 4.58% | 140404 | 4.36% | 2019-03-31 |
| D. E. Shaw & Co LP | 3846442 | 5.24% | -76410 | -1.95% | 2019-03-31 |
| State Street Corporation | 4065222 | 5.54% | 358958 | 9.69% | 2019-03-31 |
| Vanguard Group Inc | 8538277 | 11.64% | -654438 | -7.12% | 2019-03-31 |
| BlackRock Fund Advisors | 9070488 | 12.36% | 34481 | 0.38% | 2019-07-31 |
| Baillie Gifford & Co Limited. | 9540586 | 13.00% | 55642 | 0.59% | 2019-03-31 |
| BlackRock Inc | 12026132 | 16.39% | -176310 | -1.44% | 2019-03-31 |
| Disciplined Growth Investors Inc | 2852064 | 3.89% | 1511931 | 112.82% | 2019-03-31 |
| Dimensional Fund Advisors, Inc. | 2620904 | 3.57% | 87501 | 3.45% | 2019-03-31 |
| SSGA Funds Management Inc | 2586091 | 3.52% | 10814 | 0.42% | 2019-07-31 |
| Geode Capital Management, LLC | 926773 | 1.26% | -832125 | -47.31% | 2019-03-31 |
| Vanguard | 937135 | 1.28% | -74989 | -7.41% | 2019-07-31 |
| Acadian Asset Management LLC | 1506584 | 2.05% | 854995 | 131.22% | 2019-03-31 |
| Northern Trust Corp | 1691878 | 2.31% | -201 | -0.01% | 2019-03-31 |
| Northern Trust Investments N A | 1691878 | 2.31% | -201 | -0.01% | 2019-03-31 |
| Northern Trust Investments Inc | 1777247 | 2.42% | 42121 | 2.43% | 2019-07-31 |
| Vanguard Investments Australia Ltd | 1959278 | 2.67% | 338 | 0.02% | 2019-07-31 |
| Dimensional Fund Advisors LP | 2217817 | 3.02% | 90672 | 4.26% | 2019-07-31 |
| Amvescap Plc. | 1644337 | 2.24% | 213850 | 14.95% | 2018-12-31 |
| BlackRock Asset Management Canada Ltd | 10300540 | 14.04% | -27867 | -0.27% | 2019-05-31 |
| Bank of New York Mellon Corp | 985904 | 1.34% | 75872 | 8.34% | 2018-12-31 |
| Point72 Asset Management, L.P. | 936507 | 1.28% | 326187 | 53.45% | 2018-12-31 |
| Invesco Capital Management LLC | 1056428 | 1.44% | -107122 | -9.21% | 2019-02-28 |
| Thrivent Financial For Lutherans | 2372526 | 3.24% | -484320 | -16.95% | 2018-09-30 |
| Thrivent Asset Management, LLC | 1110499 | 1.49% | -157622 | -12.43% | 2018-12-31 |
| Goldman Sachs Group Inc | 1070842 | 1.43% | -506461 | -32.11% | 2018-06-30 |
| BlackRock Institutional Trust Company NA | 2079648 | 2.78% | 70486 | 3.51% | 2018-06-30 |
| Camber Capital Management LLC | 1500000 | 2.01% | -- | -- | 2018-06-30 |
| Pinnacle Associates Inc | 576773 | 0.82% | -102270 | -15.06% | 2018-06-30 |
| Principal Global Investors, LLC | 583040 | 0.83% | -662 | -0.11% | 2018-06-30 |
| Russell Investments Limited | 565782 | 0.80% | -29224 | -4.91% | 2018-08-31 |
| Charles Schwab Investment Management Inc | 767508 | 1.09% | 108303 | 16.43% | 2018-06-30 |
| Invesco PowerShares Capital Mgmt LLC | 822332 | 1.16% | 237320 | 40.57% | 2018-06-30 |
| State Street Corp | 3128672 | 4.43% | -507997 | -13.97% | 2018-06-30 |
| Allianz Global Investors Mnged Accounts | 572771 | 0.81% | 572771 | -- | 2018-06-30 |
| Goldman Sachs Asset Management LP | 552541 | 0.78% | -308352 | -35.82% | 2018-06-30 |
| Goldman, Sachs & Co. | 716410 | 1.03% | -76485 | -9.65% | 2018-03-31 |
| NORGES BANK | 1310443 | 1.89% | 47096 | 3.73% | 2017-12-31 |
| Wells Fargo Bank NA | 659508 | 0.95% | 2067 | 0.31% | 2017-12-31 |
| Baillie Gifford Life Limited | 1029471 | 1.48% | -- | -- | 2017-12-31 |
| Millennium Management LLC | 561956 | 0.81% | -850615 | -60.22% | 2017-09-30 |
| Sterling Capital Management LLC | 1848772 | 2.70% | -32878 | -1.75% | 2017-06-30 |
| Smallcap World Fund Inc | 5766556 | 8.05% | 5766556 | -- | 2015-12-31 |
| Capital Research Global Investors | 4423358 | 6.47% | -3058777 | -40.88% | 2016-09-30 |
| Scopia Management Inc | 3659647 | 5.35% | -994680 | -21.37% | 2016-09-30 |
| Renaissance Technologies Corp | 2931674 | 4.29% | 1599374 | 120.05% | 2016-09-30 |
| Citadel Advisors Llc | 1371860 | 2.01% | 1239901 | 939.61% | 2016-09-30 |
| Morgan Stanley & Co Inc | 1319227 | 1.93% | 160593 | 13.86% | 2016-09-30 |
| Neuberger Berman LLC | 1174218 | 1.72% | 1174218 | -- | 2016-09-30 |
| Iridian Asset Management LL | 3978504 | 9.00% | 145812172 | 0.10% | 1999-11-30 |
| Scopia Capital Management | 4176074 | 9.00% | 153053112 | 0.10% | 1999-11-30 |
| The Vanguard Group | 4752636 | 9.00% | 174184109 | 0.10% | 1999-11-30 |
| Royce & Associates LLC | 5084563 | 9.00% | 186349234 | 0.10% | 1999-11-30 |
| Capital World Investors | 8940000 | 9.00% | 327651000 | 0.10% | 1999-11-30 |
| Baillie Gifford& Co. | 9659003 | 9.00% | 354002460 | 0.10% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Invesco American Value Fund | 432894 | 0.59% | 49345 | 12.87% | 2019-06-30 |
| Vanguard Extended Market Index Fund | 1012007 | 1.38% | -6629 | -0.65% | 2019-06-30 |
| Baillie Gifford Global Alpha Growth Fund | 1096762 | 1.49% | -- | -- | 2019-05-31 |
| Vanguard Small Cap Value Index Fund | 1103886 | 1.50% | -44001 | -3.83% | 2019-06-30 |
| iShares Russell 2000 ETF | 1550602 | 2.11% | 23240 | 1.52% | 2019-07-30 |
| Vanguard Small Cap Index | 1778157 | 2.42% | -43364 | -2.38% | 2019-06-30 |
| SPDR | 1934300 | 2.64% | 37848 | 2.00% | 2019-07-31 |
| Vanguard Total Stock Market Index Fund | 1943812 | 2.65% | 428 | 0.02% | 2019-06-30 |
| iShares Core S&P Small-Cap ETF | 4449884 | 6.06% | 4279 | 0.10% | 2019-07-30 |
| DFA US Small Cap Portfolio | 796274 | 1.09% | -- | -- | 2019-05-31 |
| iShares Nasdaq Biotechnology ETF | 724308 | 0.99% | 6856 | 0.96% | 2019-07-30 |
| Vanguard Strategic Equity Fund | 689629 | 0.94% | -63457 | -8.43% | 2019-03-31 |
| Principal SmallCap S&P 600 Idx SP | 462156 | 0.63% | -267 | -0.06% | 2019-06-30 |
| DFA US Targeted Value Portfolio | 473195 | 0.64% | 26808 | 6.01% | 2019-05-31 |
| Vanguard Tax Managed Small Cap Fund | 510814 | 0.70% | -151400 | -22.86% | 2019-06-30 |
| Baron Discovery Fund | 545000 | 0.74% | 35436 | 6.95% | 2019-06-30 |
| iShares Russell 2000 Value ETF | 563461 | 0.77% | 1140 | 0.20% | 2019-07-31 |
| iShares S&P Small-Cap 600 Growth ETF | 565440 | 0.77% | -- | -- | 2019-07-30 |
| iShares S&P Small-Cap 600 Value ETF | 567740 | 0.77% | -- | -- | 2019-07-30 |
| Vanguard Global Equity Fund | 600039 | 0.82% | 48529 | 8.80% | 2019-03-31 |
| Invesco S&P SmallCap Health Care ETF | 439468 | 0.60% | -- | -- | 2019-06-30 |
| Monks | 402207 | 0.55% | -257 | -0.06% | 2019-04-30 |
| iShares Russell 2000 Growth ETF | 515492 | 0.70% | -566 | -0.11% | 2019-06-27 |
| iShares Core MSCI AllCntry Wld exCan ETF | 4398620 | 5.99% | -27245 | -0.62% | 2019-05-23 |
| iShares Core S&P US Total Market ETF | 4397840 | 5.99% | -- | -- | 2019-05-30 |
| iShares US Small Cap ETF (CAD-Hedged) | 1401637 | 1.91% | -2349 | -0.17% | 2019-05-30 |
| Vanguard Small Cap Index Fund | 1818791 | 2.48% | 13221 | 0.73% | 2019-04-30 |
| Columbia Small Cap Index Fund | 409170 | 0.56% | -- | -- | 2019-02-28 |
| Northern Small Cap Value Fund | 361830 | 0.49% | -- | -- | 2018-12-31 |
| Thrivent Mid Cap Stock Fund | 573425 | 0.77% | -277450 | -32.61% | 2018-10-31 |
| Thrivent Mid Cap Stock Portfolio | 518200 | 0.69% | -216050 | -29.42% | 2018-10-31 |
| Sterling Capital Special Opps Fund | 401951 | 0.54% | -576904 | -58.94% | 2017-08-31 |
| Vanguard Small Cap Value Index Inv | 1104147 | 1.56% | 9515 | 0.87% | 2018-07-31 |
| iShares Exponential Technologies | 342437 | 0.46% | -- | -- | 2018-09-12 |
| Columbia Small Cap Index Z | 385510 | 0.55% | 4480 | 1.18% | 2018-07-31 |
| Vanguard Strategic Equity Inv | 559614 | 0.79% | 76170 | 15.76% | 2018-06-30 |
| Vanguard Global Equity Inv | 634017 | 0.90% | -46369 | -6.82% | 2018-06-30 |
| Vanguard Tax-Managed Small Cap Adm | 588712 | 0.83% | 16900 | 2.96% | 2018-07-31 |
| iShares Russell 2000 Growth | 560427 | 0.75% | -540 | -0.10% | 2018-09-12 |
| iShares S&P Small-Cap 600 Growth | 1221161 | 1.63% | 15480 | 1.28% | 2018-09-12 |
| PowerShares S&P SmallCap Health Care ETF | 884832 | 1.19% | 18532 | 2.14% | 2018-09-13 |
| Vanguard Extended Market Idx Inv | 922607 | 1.31% | 6602 | 0.72% | 2018-07-31 |
| Thrivent Mid Cap Stock A | 1005375 | 1.42% | -- | -- | 2018-06-30 |
| iShares Nasdaq Biotechnology | 792902 | 1.06% | -1509 | -0.19% | 2018-09-12 |
| Thrivent Ser Mid Cap Stock | 961750 | 1.36% | -- | -- | 2018-06-30 |
| DFA US Small Cap I | 796274 | 1.13% | -- | -- | 2018-07-31 |
| DFA US Small Cap Value II | 701005 | 0.99% | -152906 | -17.91% | 2018-07-31 |
| Vanguard Total Stock Mkt Idx | 1757328 | 2.49% | 2162 | 0.12% | 2018-07-31 |
| Northern Small Cap Value | 389267 | 0.56% | -- | -- | 2018-06-30 |
| Goldman Sachs Small Cap Value A | 503362 | 0.72% | 503362 | -- | 2018-03-31 |
| iShares Russell 2000 Value | 742174 | 1.13% | -1224 | -0.16% | 2018-06-21 |
| Vanguard Strategic Small-Cap Equity Inv | 293510 | 0.42% | 293510 | -- | 2017-12-31 |
| Fidelity Spartan | 304682 | 0.44% | -- | -- | 2018-02-28 |
| DFA US Micro Cap I | 236655 | 0.34% | -1020 | -0.43% | 2017-12-31 |
| Baron Discovery Institutional | 215500 | 0.31% | -- | -- | 2017-09-30 |
| First Trust NYSE Arca Biotech ETF | 1767010 | 2.65% | -- | -- | 2017-02-08 |
| Sterling Capital Special Opps A | 988250 | 1.45% | -- | -- | 2016-12-31 |
| VA CollegeAmerica Smcap World 529E | 842400 | 1.24% | -2869856 | -77.31% | 2016-12-31 |
| American Funds IS | 401900 | 0.59% | -231517 | -36.55% | 2016-12-31 |
| PowerShares Dynamic Biotech & Genome ETF | 376880 | 0.57% | -- | -- | 2017-02-08 |
| Vident Core US Equity | 158000 | 0.22% | -- | -- | 2017-02-07 |
| Northern Trust Russell 2000 Index Fund - DC - Non-Lending | 165490 | 0.24% | 9790 | 6.29% | 2016-12-31 |
| Schwab Small-Cap Equity | 198952 | 0.29% | -- | -- | 2016-12-31 |
| VA CollegeAmerica Small Cap World | 5766556 | 8.30% | -14100 | -0.20% | 2015-09-30 |
| VA CollegeAmerica Growth Fund of America | 3579785 | 5.20% | -60215 | -1.60% | 2015-09-30 |
| American Funds NVIT Growth | 3422500 | 4.90% | -57500 | -1.60% | 2015-09-30 |
| VA CollegeAmerica New Economy | 3034663 | 4.40% | -- | -- | 2015-09-30 |
| First Trust NYSE Arca Biotech Fund | 2594332 | 3.90% | -- | -- | 2015-11-16 |
| Undrly Baillie Giff Global Alpha Pen | 1635294 | 2.40% | -- | -- | 2015-10-31 |
| Royce Premier Fund | 1477250 | 2.10% | -389000 | -20.80% | 2015-09-30 |
| Fidelity® Select Biotechnology Portfolio | 1189343 | 1.70% | -- | -- | 2015-09-30 |
| iShares Russell 2000 (AU) | 1099471 | 1.70% | -11319 | -1.00% | 2015-11-16 |
| Manulife Canadian Focused Fund | 979002 | 1.40% | -- | -- | 2015-06-30 |
| American Funds IS® Gbl Sm Cap | 1274898 | 1.80% | -- | -- | 2015-09-30 |
| Richard S. Swartz | Currently, Richard S. Swartz occupies the position of President & Chief Executive Officer for MYR Group, Inc. and President for The L.E. Myers Co. and President of Harlan Electric Co., Inc. (both are subsidiaries of MYR Group, Inc.). Mr. Swartz is also Executive Vice President at Myriad Genetics, Inc. |
|---|---|
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 1
【“牛市女皇”旗下ARKK重挫4.6%，生物科技股全线下跌】“牛市女皇”Cathie Wood旗下旗舰基金创新ETF-ARK重挫4.6%，为连续第八日下跌，本周迄今跌近12%。 美股生物制药股全线下跌，Kala制药跌超14%，Arbutus生物制药跌9%，脉冲生物科学跌近9%，Abeona Therapeutics跌超8%，太平洋生物科学跌超6%，诺瓦瓦克斯跌超5%。 基因测序股集体下跌，Invitae跌超8%，万基遗传、基因技术跌超4%。 干细胞类股集体下跌，延龄草治疗跌超7%，Verastem跌超5%。